Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hyatt Regency Bethesda

Mar 23, 2020 9:00 AM - Mar 27, 2020 1:45 PM

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Regulatory Affairs: The IND, NDA, and Post-Marketing

Continuing Education

ACPEThe Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 30.75 contact hours or 3.075 continuing education units. Type of Activity: Application

ACPE Credit Requests MUST BE SUBMITTED by Monday, May 11, 2020
DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit www.cpemonitor.net.

IACET DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).

As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer 3 CEUs for this program.

View
Continuing Education Credit Allocation

It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any relevant financial relationships related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices.

This educational activity may include references to the use of products for indications not approved by the FDA. Opinions expressed with regard to unapproved uses of products are solely those of the faculty and are not endorsed by DIA or any of the manufacturers of products mentioned herein. Faculty for this educational activity was asked to disclose any discussion of unlabeled or unapproved uses of drugs or medical devices.
Disclosure statements are included with each instructor's biographical sketch.

NameCredit TypeMax CreditsCEU
Regulatory Affairs: The IND, NDA, and Post-MarketingCredit TypeACPEMax Credits30.75CEU3.075
Regulatory Affairs: The IND, NDA, and Post-MarketingCredit TypeIACETMax Credits30.75CEU3.100

Statement of Credit:

If you would like to receive a statement of credit, you must complete the pre-course work no later than Friday, March 27, 2020, at 11:59pm ET in the DIA Learning Center, participate in the live online course, and complete the post-assessment and evaluation in the DIA Learning Center. My Transcript will be available for credit request the day on Tuesday, March 31, 2020.

Sign in to My Account to access My Transcripts and request your online credit.

To review DIA’s Disclosure and Grievance Policy, visit DIAglobal.org/CE

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.